TNFSF10 and familial pancreatic carcinoma: Additionally, although in a number of studies, MSCs expressing a secreted form of TRAIL showed a significant antitumor effect against pancreatic cancer [54] or hepatocellular carcinoma cells [55], apparently, this form of TRAIL delivery in CIMVs does not allow them to effectively bind to their receptors on the tumor cell membrane.